Composition of the Immune Environment at Baseline Correlates with Time to Response and Treatment Outcome in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (MM) Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Observation (AGMT_MM 02 Study)

I Manrique; Richard Greil; J Andel; S Sormann; BL Hartmann; K Podar; Alexander Egle; A Petzer; N Zojer; E Gunsilius; R Ruckser; B Bozic; CA Schmitt; S Machherndl-Spandl; H Agis; M Schreder; SY Wang; W Willenbacher; MT Krauth; C Tinchon; M Fillitz; Thomas Melchardt; Stefan Knop; B Paiva; H Ludwig

doi:10.1182/blood-2021-150311

Composition of the Immune Environment at Baseline Correlates with Time to Response and Treatment Outcome in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (MM) Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Observation (AGMT_MM 02 Study)

I Manrique
, Richard Greil
, J Andel
, S Sormann
, BL Hartmann
, K Podar
, Alexander Egle
, A Petzer
, N Zojer
, E Gunsilius
, R Ruckser
, B Bozic
, CA Schmitt
, S Machherndl-Spandl
, H Agis
, M Schreder
, SY Wang
, W Willenbacher
, MT Krauth
, C Tinchon

M Fillitz, Thomas Melchardt, Stefan Knop, B Paiva, H Ludwig

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Fachzeitschrift	BLOOD
Jahrgang	138
DOIs	https://doi.org/10.1182/blood-2021-150311
Publikationsstatus	Veröffentlicht - 2021

Zugriff auf Dokument

10.1182/blood-2021-150311

Dieses zitieren

Manrique, I., Greil, R., Andel, J., Sormann, S., Hartmann, BL., Podar, K., Egle, A., Petzer, A., Zojer, N., Gunsilius, E., Ruckser, R., Bozic, B., Schmitt, CA., Machherndl-Spandl, S., Agis, H., Schreder, M., Wang, SY., Willenbacher, W., Krauth, MT., ... Ludwig, H. (2021). Composition of the Immune Environment at Baseline Correlates with Time to Response and Treatment Outcome in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (MM) Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Observation (AGMT_MM 02 Study). BLOOD , 138. https://doi.org/10.1182/blood-2021-150311

Manrique, I ; Greil, Richard ; Andel, J et al. / Composition of the Immune Environment at Baseline Correlates with Time to Response and Treatment Outcome in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (MM) Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Observation (AGMT_MM 02 Study). in: BLOOD 2021 ; Jahrgang 138.

@article{9257ec64fbba4a20ac17bd01aa072fcb,

title = "Composition of the Immune Environment at Baseline Correlates with Time to Response and Treatment Outcome in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (MM) Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Observation (AGMT\_MM 02 Study)",

author = "I Manrique and Richard Greil and J Andel and S Sormann and BL Hartmann and K Podar and Alexander Egle and A Petzer and N Zojer and E Gunsilius and R Ruckser and B Bozic and CA Schmitt and S Machherndl-Spandl and H Agis and M Schreder and SY Wang and W Willenbacher and MT Krauth and C Tinchon and M Fillitz and Thomas Melchardt and Stefan Knop and B Paiva and H Ludwig",

year = "2021",

doi = "10.1182/blood-2021-150311",

language = "English",

volume = "138",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

}

Manrique, I, Greil, R, Andel, J, Sormann, S, Hartmann, BL, Podar, K, Egle, A, Petzer, A, Zojer, N, Gunsilius, E, Ruckser, R, Bozic, B, Schmitt, CA, Machherndl-Spandl, S, Agis, H, Schreder, M, Wang, SY, Willenbacher, W, Krauth, MT, Tinchon, C, Fillitz, M, Melchardt, T , Knop, S, Paiva, B & Ludwig, H 2021, 'Composition of the Immune Environment at Baseline Correlates with Time to Response and Treatment Outcome in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (MM) Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Observation (AGMT_MM 02 Study)', BLOOD , Jg. 138. https://doi.org/10.1182/blood-2021-150311

Composition of the Immune Environment at Baseline Correlates with Time to Response and Treatment Outcome in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (MM) Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Observation (AGMT_MM 02 Study). / Manrique, I; Greil, Richard; Andel, J et al.
in: BLOOD , Jahrgang 138, 2021.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Composition of the Immune Environment at Baseline Correlates with Time to Response and Treatment Outcome in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (MM) Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Observation (AGMT_MM 02 Study)

AU - Manrique, I

AU - Greil, Richard

AU - Andel, J

AU - Sormann, S

AU - Hartmann, BL

AU - Podar, K

AU - Egle, Alexander

AU - Petzer, A

AU - Zojer, N

AU - Gunsilius, E

AU - Ruckser, R

AU - Bozic, B

AU - Schmitt, CA

AU - Machherndl-Spandl, S

AU - Agis, H

AU - Schreder, M

AU - Wang, SY

AU - Willenbacher, W

AU - Krauth, MT

AU - Tinchon, C

AU - Fillitz, M

AU - Melchardt, Thomas

AU - Knop, Stefan

AU - Paiva, B

AU - Ludwig, H

PY - 2021

Y1 - 2021

U2 - 10.1182/blood-2021-150311

DO - 10.1182/blood-2021-150311

M3 - Abstract (Journal)

SN - 0006-4971

VL - 138

JO - BLOOD

JF - BLOOD

ER -

Manrique I, Greil R, Andel J, Sormann S, Hartmann BL, Podar K et al. Composition of the Immune Environment at Baseline Correlates with Time to Response and Treatment Outcome in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (MM) Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Observation (AGMT_MM 02 Study). BLOOD . 2021;138. doi: 10.1182/blood-2021-150311